The rapidly-mutating SARS-CoV-2 virus is testing the resilience of the world’s responses, with some variants evolving to become more infectious, and threatening a third wave.
Dr Harry Al-Wassiti, Research Fellow at the Monash Institute of Pharmaceutical Sciences (MIPS), answers the questions about the jab that's on everyone's mind.
Dummy text
